Recursion Pharmaceuticals: Q3 Earnings Insights

Recursion Pharmaceuticals RXRX reported its Q3 earnings results on Thursday, November 9, 2023 at 07:58 AM.

Here's what investors need to know about the announcement.

Recursion Pharmaceuticals missed estimated earnings by 13.16%, reporting an EPS of $-0.43 versus an estimate of $-0.38.

Revenue was down $2.63 million from the same period last year.

Last quarter the company missed on EPS by $0.01 which was followed by a 5.02% drop in the share price the next day.

Here's a look at Recursion Pharmaceuticals's past performance:

Quarter	Q2 2023	Q1 2023	Q4 2022	Q3 2022
EPS Estimate	-0.37	-0.35	-0.29	-0.38
EPS Actual	-0.38	-0.34	-0.31	-0.35
Revenue Estimate	11.91M	14.44M	24.00M	6.97M
Revenue Actual	11.02M	12.13M	13.68M	13.16M

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Recursion Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar